En resumen
Office of Assistant Secretary for Preparedness and Response, entidad pública de Estados Unidos, publicó esta licitación. Por las palabras de su título la etiquetamos como salud. Las ofertas se presentan en SAM.gov hasta el 20 de noviembre de 2026 (faltan 54 días). El plazo total para ofertar es de 70 días. El portal no publica un valor estimado.
Ficha
| Entidad compradora | Office of Assistant Secretary for Preparedness and Response |
|---|---|
| Valor estimado | valor no publicado en el portal |
| Cierre de ofertas | 20 de noviembre de 2026, 22:00 (hora de UTC) |
| Publicada | 11 de septiembre de 2026 |
| País | Estados Unidos · SAM.gov |
| Número de proceso | d547606225884278817f5008d9a07e99 |
| Códigos de categoría | NAICS 541714, PSC AN12 |
Fechas
Publicada11 sep 2026Cierre de ofertas20 nov 2026 · 22:00 (hora de UTC)
Descripción oficial
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods. Mandatory Qualification Requirements: To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by: 1. Holding a U.S. influenza vaccine license; or 2. Have developed an influenza vaccine as evidenced by: a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine Please see full solicitation details and proposal submission instructions detailed in attachments 01-19 of this notice.
Cómo participar
- Registra tu empresa en SAM.gov (es gratis) para obtener el identificador único de entidad (UEI). La mayoría de las solicitudes exigen el registro activo al presentar la oferta, y el trámite puede tardar varias semanas.
- Abre el aviso en SAM.gov y lee la solicitud, sus anexos y cada enmienda.
- Presenta tu oferta exactamente como indica el aviso, antes de la fecha de respuesta.